Aquestive Therapeutics (AQST) Debt to Equity: 2017-2024
Historic Debt to Equity for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -$0.54.
- Aquestive Therapeutics' Debt to Equity fell 1181.69% to -$8.83 in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.10, marking a year-over-year decrease of 4996.83%. This contributed to the annual value of -$0.54 for FY2024, which is 109.14% down from last year.
- As of FY2024, Aquestive Therapeutics' Debt to Equity stood at -$0.54, which was down 109.14% from -$0.26 recorded in FY2023.
- In the past 5 years, Aquestive Therapeutics' Debt to Equity registered a high of -$0.26 during FY2023, and its lowest value of -$0.76 during FY2020.
- In the last 3 years, Aquestive Therapeutics' Debt to Equity had a median value of -$0.44 in 2022 and averaged -$0.41.
- Per our database at Business Quant, Aquestive Therapeutics' Debt to Equity skyrocketed by 92.28% in 2020 and then plummeted by 109.14% in 2024.
- Over the past 5 years, Aquestive Therapeutics' Debt to Equity (Yearly) stood at -$0.76 in 2020, then climbed by 14.28% to -$0.65 in 2021, then surged by 32.57% to -$0.44 in 2022, then soared by 41.23% to -$0.26 in 2023, then crashed by 109.14% to -$0.54 in 2024.